Action Type | Duplicate Counter | Action Date | Document Type | Application Document ID | Sequence Number | Document Title | Document URL | Document Date |
AP | 0 | 11/27/2002 | N | 2877 | 000 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21365ltr.pdf
| 11/27/2002 |
AP | 0 | 11/27/2002 | N | 2878 | 000 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21365_Lexapro_lbl.pdf
| 11/27/2002 |
AP | 0 | 11/27/2002 | N | 9596 | 000 | |
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-365_Lexapro.cfm
| 6/29/2004 |
AP | 0 | 11/27/2002 | N | 12370 | 000 | |
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm053342.htm
| 7/29/2005 |
AP | 0 | 11/27/2002 | N | 24007 | 000 | |
http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088620.pdf
| 11/19/2009 |
AP | 0 | 12/18/2003 | SE8 | 7299 | 001 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21323se1-003,se8-007,21365se8-001,se1-004ltr.pdf
| 12/22/2003 |
AP | 0 | 12/18/2003 | SE8 | 7314 | 001 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21323se1-003,se8-007,21365se8-001,se1-004_lexapro_lbl.pdf
| 12/22/2003 |
AP | 0 | 12/18/2003 | SE8 | 17016 | 001 | |
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021323_S007&021365_S001_LEXAPRO_TABS.pdf
| 7/6/2007 |
AP | 0 | 12/18/2003 | SE1 | 7300 | 004 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21323se1-003,se8-007,21365se8-001,se1-004ltr.pdf
| 12/22/2003 |
AP | 0 | 12/18/2003 | SE1 | 7315 | 004 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21323se1-003,se8-007,21365se8-001,se1-004_lexapro_lbl.pdf
| 12/22/2003 |
AP | 0 | 12/18/2003 | SE1 | 17013 | 004 | |
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021323_S003&021365_S004_LEXAPRO_TABS.pdf
| 7/6/2007 |
AP | 0 | 4/8/2004 | S | | | |
| |
AP | 0 | 1/11/2005 | SLR | 10954 | 007 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/21323s014,21365s007ltr.pdf
| 1/13/2005 |
AP | 0 | 5/20/2004 | SLR | 8652 | 008 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20822slr027,21046slr007,21323slr015,21365slr008ltr.pdf
| 5/26/2004 |
AP | 0 | 2/18/2005 | SLR | 11146 | 012 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/20822s029,21046s009,21323s020,21365s012ltr.pdf
| 2/23/2005 |
AP | 0 | 8/2/2007 | SLR | | | |
| |
AP | 0 | 9/17/2008 | SLR | 20852 | 018 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021323s028,s029,021365s018,s019ltr.pdf
| 9/19/2008 |
AP | 0 | 9/17/2008 | SLR | 20863 | 018 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021323s28s29,021365s18s19lbl.pdf
| 9/19/2008 |
AP | 0 | 10/11/2008 | SLR | 21040 | 019 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021323s029, 021365s019ltr.pdf
| 10/21/2008 |
AP | 0 | 3/19/2009 | SE5 | 22089 | 021 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021323s030,s031,021365s021,s022ltr.pdf
| 3/24/2009 |
AP | 0 | 3/19/2009 | SE5 | 22111 | 021 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021323s030s031,021365s021s022lbl.pdf
| 3/25/2009 |
AP | 0 | 3/19/2009 | SE5 | 22090 | 022 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021323s030,s031,021365s021,s022ltr.pdf
| 3/24/2009 |
AP | 0 | 3/19/2009 | SE5 | 22112 | 022 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021323s030s031,021365s021s022lbl.pdf
| 3/25/2009 |
AP | 0 | 1/30/2009 | SLR | 21726 | 023 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020822s037,021046s015,021323s032,021365s023ltr.pdf
| 2/3/2009 |
AP | 0 | 1/30/2009 | SLR | 21774 | 023 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021323s032,021365s023lbl.pdf
| 2/4/2009 |
AP | 0 | 5/12/2011 | SLR | 28813 | 024 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021323s033,021365s024ltr.pdf
| 5/16/2011 |
AP | 0 | 5/12/2011 | SLR | 28831 | 024 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021323s033,021365s024MedG.pdf
| 5/16/2011 |
AP | 0 | 5/12/2011 | SLR | 28833 | 024 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021323s033,021365s024lbl.pdf
| 5/16/2011 |
AP | 0 | 3/11/2011 | SLR | 28219 | 025 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021323s035,021365s025lbl.pdf
| 3/11/2011 |
AP | 0 | 3/11/2011 | SLR | 28257 | 025 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021323s035,021365s025ltr.pdf
| 3/16/2011 |
AP | 0 | 12/3/2012 | SLR | 34530 | 030 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021365s030lbl.pdf
| 12/3/2012 |
AP | 0 | 12/3/2012 | SLR | 34555 | 030 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020822Org1s043,021046Orig1s020,021323Orig1s040,021365Orig1s030ltr.pdf
| 12/5/2012 |
AP | 0 | 10/31/2014 | SLR | 40922 | 032 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021323Orig1s044,021365Orig1s032ltr.pdf
| 11/3/2014 |
AP | 0 | 10/31/2014 | SLR | 40943 | 032 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021323s044,021365s032lbl.pdf
| 11/4/2014 |
AP | 0 | 7/8/2014 | SLR | 39833 | 033 | |
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/020822Orig1s046,021323Orig1s045,021365Orig1s033ltr.pdf
| 7/10/2014 |
AP | 0 | 7/8/2014 | SLR | 39909 | 033 | |
http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021323Orig1s045,021365Orig1s033lbl.pdf
| 7/21/2014 |